Drugs & TargetsFree FDA finalizes policy on labeling for accelerated approval drugs January 25, 2019Vol.45 No.04
Drugs & TargetsFree FDA grants Illumina’s TruSight Assay Breakthrough Device designation January 25, 2019Vol.45 No.04
Drugs & TargetsFree Genmab initiates of FDA submission for expansion of daratumumab in multiple myeloma January 25, 2019Vol.45 No.04
Drugs & Targets FDA approves Cabometyx for previously treated hepatocellular carcinoma January 18, 2019Vol.45 No.03
Drugs & Targets European Commission approves Opdivo + low-dose Yervoy in RCC January 18, 2019Vol.45 No.03
Drugs & Targets QIAGEN receives approval for EGFR test in lung cancer as companion diagnostic in Japan January 18, 2019Vol.45 No.03
Drugs & Targets FDA accepts sBLA for Tecentriq + Abraxane and carboplatin for lung cancer January 18, 2019Vol.45 No.03
Drugs & Targets Gottlieb warns FDA has about one month of user fee funds left January 11, 2019Vol.45 No.02
Drugs & Targets FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition January 11, 2019Vol.45 No.02
